Skip to content
Home / Companies / RPRX RPR
Royalty Pharma plc (RPRX) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest RPRX Insider Trades
About Royalty Pharma plc (RPRX) Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
Headquarters NEW YORK, NY
Employees 100
Listed 2020
Exchange XNAS https://www.royaltypharma.com SEC filings for RPRX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 11 409,199 $23.16M Grant or award 13 132,521 Bona-fide gift 4 68,300
RPRX Insider Transactions (Form 4) 62 65 Form 4 filings on record, the earliest from May 13, 2025, newest first. Filing history page 2 of 3.
Date Insider Transaction Security Shares Price Value Mar 23, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 32,916
Recent RPRX Form 8-K Filings 5
Recent RPRX Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 18, 2026 SCH Investment Partners LLC Officer 100,000 $6.01M View on EDGAR Aug 13, 2026 Terrance Coyne Officer
RPRX Insider Trading - FAQ
What is the latest insider trade for RPRX? Royalty Pharma plc (RPRX) had 19 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for RPRX runs to 65 Form 4 filings, the earliest from 2025-05-13. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying RPRX stock? No insider purchases of RPRX were filed in the last 90 days.
How many insiders are selling RPRX stock? 11 insider sales of RPRX were filed in the last 90 days, totaling $23.16M.
Where can I see RPRX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks RPRX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow RPRX insider buys? Create a free InsiderAlpha account and press Watch on this page to add RPRX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track RPRX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Aug 13, 2026
Market cap $27.10B
P/E ratio -
Dividend yield -
Average volume 3.36M
52 week high $62.46
52 week low $34.08
Today's high -
Today's low -
Open -
Volume -
Previous close $60.85
Shares outstanding 445.28M Market cap
$27.10B
100 employees
RPRX Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 11 sales totaling $23.16M.
Most-Active RPRX Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Mar 23, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 1,875 $45.53 $85K
Mar 2, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 22,487 $46.67 $1.05M
Mar 2, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 10,429 $47.01 $490K
Mar 2, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 1,292 $46.67 $60K
Mar 2, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 583 $47.01 $27K
Feb 23, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 32,916 $45.32 $1.49M
Feb 23, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 1,875 $45.32 $85K
Feb 11, 2026 PL Pablo G. Legorreta - Officer Grant or award Class A Ordinary Shares 157,828 $0.00 -
Feb 11, 2026 TC Terrance P. Coyne - Officer Grant or award Class A Ordinary Shares 26,626 $0.00 -
Feb 11, 2026 CH Christopher Hite - Officer Grant or award Class A Ordinary Shares 26,626 $0.00 -
Feb 11, 2026 MU Marshall Urist - Officer Grant or award Class A Ordinary Shares 19,970 $0.00 -
Feb 2, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 102,581 $42.08 $4.32M
Feb 3, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 108,759 $42.84 $4.66M
Feb 4, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 19,076 $43.29 $826K
Feb 2, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 5,843 $42.08 $246K
Feb 3, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 6,195 $42.84 $265K
Feb 4, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 1,087 $43.29 $47K
Jan 30, 2026 MU Marshall Urist - Officer Open-market sale Class A Ordinary Shares 20,000 $41.09 $822K
Jan 23, 2026 MU Marshall Urist - Officer Open-market sale Class A Ordinary Shares 20,000 $40.26 $805K
Jan 20, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 65,832 $39.35 $2.59M
Jan 20, 2026 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 3,750 $39.35 $148K
Jan 16, 2026 MU Marshall Urist - Officer Open-market sale Class A Ordinary Shares 20,000 $39.52 $790K
Dec 3, 2025 GL George W. Lloyd - Officer Open-market sale Class A Ordinary Shares 110,000 $39.77 $4.38M
Dec 1, 2025 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 65,832 $39.87 $2.62M
Dec 1, 2025 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 3,750 $39.87 $149K
Dec 1, 2025 MU Marshall Urist - Officer Open-market sale Class A Ordinary Shares 23,333 $39.93 $932K
Dec 1, 2025 MU Marshall Urist - Officer Open-market sale Class A Ordinary Shares 18,242 $39.90 $728K
Nov 24, 2025 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 55,146 $38.67 $2.13M
Nov 24, 2025 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 10,686 $37.96 $406K
Nov 24, 2025 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 3,126 $38.67 $121K
Nov 24, 2025 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 624 $37.96 $24K
Nov 19, 2025 GL George W. Lloyd - Officer Open-market sale Class A Ordinary Shares 47,798 $38.28 $1.83M
Nov 19, 2025 GL George W. Lloyd - Officer Open-market sale Class A Ordinary Shares 4,628 $39.01 $181K
Nov 19, 2025 GL George W. Lloyd - Officer Open-market sale Class A Ordinary Shares 47,401 $38.28 $1.81M
Nov 19, 2025 GL George W. Lloyd - Officer Open-market sale Class A Ordinary Shares 4,599 $39.01 $179K
Nov 19, 2025 GL George W. Lloyd - Officer Open-market sale Class A Ordinary Shares 25,530 $38.28 $977K
Nov 19, 2025 GL George W. Lloyd - Officer Open-market sale Class A Ordinary Shares 2,470 $39.01 $96K
Nov 19, 2025 GL George W. Lloyd - Officer Open-market sale Class A Ordinary Shares 2,770 $38.29 $106K
Nov 19, 2025 GL George W. Lloyd - Officer Open-market sale Class A Ordinary Shares 230 $39.03 $9K
Nov 17, 2025 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 65,844 $39.30 $2.59M
Nov 17, 2025 TC Terrance P. Coyne - Officer Open-market sale Class A Ordinary Shares 3,750 $39.30 $147K
Nov 5, 2025 GL George W. Lloyd - Officer Grant or award Class A Ordinary Shares 6,168 $0.00 -
Nov 7, 2025 MU Marshall Urist - Officer Other LP interests in RPI US Partners 2019, LP 16,000 $0.00 -
Nov 5, 2025 MU Marshall Urist - Officer Grant or award Class A Ordinary Shares 4,626 $0.00 -
Nov 7, 2025 MU Marshall Urist - Officer Other Class A Ordinary Shares 160,000 $0.00 -
Nov 5, 2025 TC Terrance P. Coyne - Officer Grant or award Class A Ordinary Shares 6,168 $0.00 -
Nov 5, 2025 CH Christopher Hite - Officer Grant or award Class A Ordinary Shares 6,168 $0.00 -
Nov 5, 2025 PL Pablo G. Legorreta - Officer Grant or award Class A Ordinary Shares 36,559 $0.00 -
Sep 30, 2025 BB Bonnie L. Bassler - Director Grant or award Class A Ordinary Shares 1,047 $35.79 $37K
Aug 8, 2025 GN Gregory Norden - Director Other Class A Ordinary Shares 144,660 $0.00 -
Aug 11, 2025 GN Gregory Norden - Director Open-market sale Class A Ordinary Shares 33,500 $36.23 $1.21M
Aug 8, 2025 GN Gregory Norden - Director Other LP interests in RPI US Partners 2019, LP 14,466 $0.00 -
Aug 6, 2025 MU Marshall Urist - Officer Grant or award Class A Ordinary Shares 2,772 $0.00 -
Aug 8, 2025 MU Marshall Urist - Officer Gift LP interests in RPI US Partners 2019, LP 3,000 $0.00 -
Aug 6, 2025 GL George W. Lloyd - Officer Grant or award Class A Ordinary Shares 3,696 $0.00 -
Aug 8, 2025 GL George W. Lloyd - Officer Gift LP interests in RPI US Partners 2019, LP 8,500 $0.00 -
Aug 6, 2025 PL Pablo G. Legorreta - Officer Grant or award Class A Ordinary Shares 21,901 $0.00 -
Aug 8, 2025 PL Pablo G. Legorreta - Officer Gift LP interests in RPI US Partners 2019, LP 60,000 $0.00 -
Aug 6, 2025 CH Christopher Hite - Officer Grant or award Class A Ordinary Shares 3,696 $0.00 -
Aug 6, 2025 TC Terrance P. Coyne - Officer Grant or award Class A Ordinary Shares 3,696 $0.00 -
Aug 8, 2025 TC Terrance P. Coyne - Officer Gift LP interests in RPI US Partners 2019, LP 1,000 $0.00 -
Aug 12, 2026 Errol B. De Souza Former Affiliate 206,352 $11.93M View on EDGAR
RZL $IONS
IONIS PHARMACEUTICALS INC
